和元生物
1 known investors
Find your way into 和元生物
Sign up to see every warm intro you have to 和元生物
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 和元生物 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
The company works with recombinant adeno-associated virus (rAAV) vectors, which are engineered from non-pathogenic wild-type AAV, for use in gene research and gene therapy applications.
Investors · 1
Frequently asked questions
- What does 和元生物 do?
- The company works with recombinant adeno-associated virus (rAAV) vectors, which are engineered from non-pathogenic wild-type AAV, for use in gene research and gene therapy applications.
- Who are 和元生物's investors?
- 和元生物's investors include Zhejiang Sino Wisdom Investment Co.,Ltd..